Multiple dose Phase II study of IPH1101 in monotherapy or associated with a low dose of IL2 (2MIU) in non previously treated hepatitis C patients

Update Il y a 4 ans
Reference: EUCTR2007-002139-94

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to assess the effect on viral load of IPH1101 administered in monotherapy or in association with a low dose of IL2 (2 MIU) in naïve hepatitis C patients.


Inclusion criteria

  • Non previously treated Hepatitis C patients

Links